(855) 447-5522 info@gatewaypharmacology.com

Our Team

Brian R. Bond, PhD
President and CEO

Brian has 25 years of experience in the pharmaceutical industry successfully leading both discovery and development teams responsible for advancing five compounds from Lead Development through Phase II clinical studies. He served as Discovery representative on a Global Development Team responsible for the early development portfolio of treatments for cardiovascular and metabolic diseases including hypertension,
nephropathy, heart failure and diabetes, as well as Pharmacology advisor to a Global Review Committee responsible for critiquing all compounds entering pre-clinical development and CVMED In-Licensing opportunities. Dr. Bond currently serves as pharmacology specialist to the NIH Cardiovascular SBIR Scientific Review panel. Dr. Bond received a B.S. in Biology at Baylor University and a Ph.D. in Physiology from the Medical University of South Carolina.

Ying Yu, MS, MD
Vice President and CSO

Ying has over 25 years of experience in cardiovascular, metabolic and chronic kidney disease research, drug discovery and development. During her 12-year career with Pfizer R&D, she served as the pharmacology leader of multiple pre-clinical project teams, generating IND-enabling pharmacology data packages and corresponding documentation responsible for the advancement of multiple quality lead drug candidates into clinical trials. She has in-depth knowledge of translational pharmacology and extensive experience in design and execution of pre-clinical pharmacology studies and data analysis and interpretation. Dr. Yu received an M.D. from Anhui Medical University, China, and a M.S. in Physiology from University of North Texas Health Science Center.

Heather Faulkner, MS
Lab Manager and Research Scientist

Heather has 20 years of experience in the pharmaceutical industry as a GLP toxicology/safety pharmacologist and R&D scientist. She has developed and conducted animal models in oncology, pain management, metabolic disease, nephrology and cardiology as well as cardiovascular safety pharmacology. She also has surgical experience in rat cannulation and nephrectomy. Heather received a B.S. in Biology at Rutgers University and a M.S. in Animal Biology from East Stroudsburg University.

Jim Nuckolls, BS
Research Scientist

Jim has over 30 years of experience in in vivo pharmacology. He has worked with numerous species and is proficient with multiple technical procedures. Jim has supported a range of disease models and is particularly skilled in rodent surgical procedures. He is AALAS LATG certified and is an Academy of Surgical Research: Surgical Research Technician (SRT).

Dean McGraw, BS
Cardiovascular Pharmacologist

Dean has over 30 years of experience in the pharmaceutical industry successfully developing, validating and conducting preclinical animal models of pharmacology and disease that have supported the advancement of several compounds into clinical development. He has conducted numerous surgical models of cardiovascular disease including radiotelemetry, vascular cannulations, ischemia and renal function. Dean has a B.S. in Animal Science from Iowa State University.

Pharmacology Support Team

Our pharmacology support team consists of former pharmaceutical researchers and highly trained technical staff who have collective experience in planning and conducting preclinical pharmacology studies and handling sophisticated data. Our team is highly skilled in performing surgical procedures including vascular cannulation, radio-telemetry transmitter implantation, and numerous other surgical models as well as routine dosing and sample collection. Most importantly, they understand the importance of attention to detail, accuracy and precision.